Back to Top
Vixarelimab Biosimilar - Research Grade
$710.00 - $6,900.00
Vixarelimab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
OSMRï؟½
Concentration
5mg/ml
Isotype
IgG4-G1 - lambda2
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
Q99650
Shipping Conditions
Blue ice
Background
Oncostatin M receptor (OSMR) transmits signals from the IL-6-family cytokine oncostatin M, influencing inflammation, fibrosis, and itch pathways studied in dermatology and immunology research. This product is an unconjugated, non-therapeutic analog of vixarelimab, a recombinant human antibody against OSMR, supplied for research use only (RUO). It is purified to a low-endotoxin standard suitable for in vivo experiments and produced in scalable milligram to gram quantities for high-throughput and bulk laboratories. Researchers use it for receptor-blocking and binding assays, in vitro OSM-signaling screens, control work, and preclinical inflammation and fibrosis models.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review













